VYNE Therapeutics Inc.VYNENASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank60
3Y CAGR-62.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-62.7%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 2.50% |
| 2024 | -34.06% |
| 2023 | 13.22% |
| 2022 | 48.20% |
| 2021 | 58.88% |
| 2020 | -110.57% |
| 2019 | -23.45% |
| 2018 | -86.69% |
| 2017 | -1132.96% |
| 2016 | 45.23% |